Skip to main content
Top
Published in: Journal of Urban Health 6/2009

01-11-2009

Should Pharmacists have a Role in Harm Reduction Services for IDUs? A Qualitative Study in Tallinn, Estonia

Authors: Sigrid Vorobjov, Anneli Uusküla, Katri Abel-Ollo, Ave Talu, Don Des Jarlais

Published in: Journal of Urban Health | Issue 6/2009

Login to get access

Abstract

Despite the high number of injecting drug users (IDUs) in Estonia, little is known about involving pharmacies into human immunodeficiency virus (HIV) prevention activities and potential barriers. Similarly, in other Eastern European countries, there is a need for additional sources for clean syringes besides syringe exchange programmes (SEPs), but data on current practices relating to pharmacists’ role in harm reduction strategies is scant. Involving pharmacies is especially important for several reasons: they have extended hours of operation and convenient locations compared to SEPs, may provide access for IDUs who have avoided SEPs, and are a trusted health resource in the community. We conducted a series of focus groups with pharmacists and IDUs in Tallinn, Estonia, to explore their attitudes toward the role of pharmacists in HIV prevention activities for IDUs. Many, but not all, pharmacists reported a readiness to sell syringes to IDUs to help prevent HIV transmission. However, negative attitudes toward IDUs in general and syringe sales to them specifically were identified as important factors restricting such sales. The idea of free distribution of clean syringes or other injecting equipment and disposal of used syringes in pharmacies elicited strong resistance. IDUs stated that pharmacies were convenient for acquiring syringes due to their extended opening hours and local distribution. IDUs were positive toward pharmacies, although they were aware of stigma from pharmacists and other customers. They also emphasized the need for distilled water and other injection paraphernalia. In conclusion, there are no formal or legislative obstacles for providing HIV prevention services for IDUs at pharmacies. Addressing negative attitudes through educational courses and involving pharmacists willing to be public health educators in high drug use areas would improve access for HIV prevention services for IDUs.
Literature
2.
go back to reference Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003; 26: 171-184.CrossRefPubMed Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003; 26: 171-184.CrossRefPubMed
3.
go back to reference Uusküla A, McNutt LA, Dehovitz J, Fischer K, Heimer R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS. 2007; 18: 41-46.CrossRefPubMed Uusküla A, McNutt LA, Dehovitz J, Fischer K, Heimer R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS. 2007; 18: 41-46.CrossRefPubMed
4.
go back to reference Sarang A, Rhodes T, Platt L. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy. 2008; 19(Suppl 1): 25-36.CrossRef Sarang A, Rhodes T, Platt L. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy. 2008; 19(Suppl 1): 25-36.CrossRef
5.
go back to reference Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduct J. 2009; 6:3.CrossRefPubMed Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduct J. 2009; 6:3.CrossRefPubMed
6.
go back to reference Platt L, Bobrova N, Rhodes T, et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS. 2006; 20: 2120-2123.CrossRefPubMed Platt L, Bobrova N, Rhodes T, et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS. 2006; 20: 2120-2123.CrossRefPubMed
7.
go back to reference Aceijas C, Hickman M, Donoghoe MC, Burrows D, Stuikyte R. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia. Addiction. 2007; 102: 1244-1250.CrossRefPubMed Aceijas C, Hickman M, Donoghoe MC, Burrows D, Stuikyte R. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia. Addiction. 2007; 102: 1244-1250.CrossRefPubMed
8.
go back to reference Bryant J, Treloar C. Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. Int J Drug Policy. 2006; 17: 418-424.CrossRef Bryant J, Treloar C. Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. Int J Drug Policy. 2006; 17: 418-424.CrossRef
9.
go back to reference Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille, France. Am J Public Health. 1999; 89: 1852-1854.CrossRefPubMed Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille, France. Am J Public Health. 1999; 89: 1852-1854.CrossRefPubMed
10.
go back to reference Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002; 79: 257-265.PubMed Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002; 79: 257-265.PubMed
12.
go back to reference Sheridan J, Strang J, Taylor C, Barber N. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists’ attitudes and their involvement in service specific training. Addiction. 1997; 92: 1737-1748.CrossRefPubMed Sheridan J, Strang J, Taylor C, Barber N. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists’ attitudes and their involvement in service specific training. Addiction. 1997; 92: 1737-1748.CrossRefPubMed
13.
go back to reference Lurie P, Jones TS, Foley J. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? J Acquir Immune Defic Syndr Human Retrovirol. 1998; 18: 45-51. Lurie P, Jones TS, Foley J. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? J Acquir Immune Defic Syndr Human Retrovirol. 1998; 18: 45-51.
14.
go back to reference Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. J Am Pharm Assoc. 2002; 42: 73-76.CrossRef Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. J Am Pharm Assoc. 2002; 42: 73-76.CrossRef
15.
go back to reference Deren S, Fuller C, Pouget E, et al. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy. 2003; 14: 373-379.CrossRef Deren S, Fuller C, Pouget E, et al. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy. 2003; 14: 373-379.CrossRef
16.
go back to reference Glanz A, Byrne C, Jackson P. Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ. 1989; 299: 1076-1079.CrossRefPubMed Glanz A, Byrne C, Jackson P. Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ. 1989; 299: 1076-1079.CrossRefPubMed
17.
go back to reference Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97: 117-124.CrossRefPubMed Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97: 117-124.CrossRefPubMed
18.
go back to reference Volmer D, Vendla K, Vetka A, Bell JS, Hamilton D. Pharmaceutical care in community pharmacies: practice and research in Estonia. Ann Pharmacother. 2008; 42: 1104-1111.CrossRefPubMed Volmer D, Vendla K, Vetka A, Bell JS, Hamilton D. Pharmaceutical care in community pharmacies: practice and research in Estonia. Ann Pharmacother. 2008; 42: 1104-1111.CrossRefPubMed
20.
go back to reference Morgan DL. Focus Groups as Qualitative Research. California: Sage Newbury Park; 1988. Morgan DL. Focus Groups as Qualitative Research. California: Sage Newbury Park; 1988.
21.
go back to reference Mack N, Woodsong C, MacQueen KM, Quest G, Namey E. Qualitative Research Methods: A Data Collector’s Field Guide. North Carolina: Family Health International; 2005. Mack N, Woodsong C, MacQueen KM, Quest G, Namey E. Qualitative Research Methods: A Data Collector’s Field Guide. North Carolina: Family Health International; 2005.
22.
go back to reference Nvivo qualitative data analysis software; QSR International Pty Ltd. Version 8, 2008. Nvivo qualitative data analysis software; QSR International Pty Ltd. Version 8, 2008.
23.
go back to reference Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. BMJ. 1996; 313: 272-274.PubMed Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. BMJ. 1996; 313: 272-274.PubMed
24.
go back to reference Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ. 1996; 313: 270-272.PubMed Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ. 1996; 313: 270-272.PubMed
25.
go back to reference Matheson C, Bond CM, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction. 2002; 97: 1405-1411.CrossRefPubMed Matheson C, Bond CM, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction. 2002; 97: 1405-1411.CrossRefPubMed
26.
go back to reference Thein HH, Denoe M, van Beek I, Dore G, MacDonald M. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy. 2003; 14: 425-430.CrossRef Thein HH, Denoe M, van Beek I, Dore G, MacDonald M. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy. 2003; 14: 425-430.CrossRef
27.
go back to reference Farley TA, Niccolai LM, Billeter M, Kissinger PJ, Grace M. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc (Wash). 1999; 39: 23-26. Farley TA, Niccolai LM, Billeter M, Kissinger PJ, Grace M. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc (Wash). 1999; 39: 23-26.
28.
go back to reference Lewis BA, Koester SK, Bush TW. Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc (Wash). 2002; 42: S46-S51.CrossRef Lewis BA, Koester SK, Bush TW. Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc (Wash). 2002; 42: S46-S51.CrossRef
29.
go back to reference Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42: S68-S72.CrossRef Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42: S68-S72.CrossRef
30.
go back to reference Matheson C, Bond CM, Mollison J. Attitudinal factors associated with community pharmacists’ involvement in services for drug misusers. Addiction. 1999; 94: 1349-1359.CrossRefPubMed Matheson C, Bond CM, Mollison J. Attitudinal factors associated with community pharmacists’ involvement in services for drug misusers. Addiction. 1999; 94: 1349-1359.CrossRefPubMed
31.
go back to reference Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists’ attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000; 77: 781-793.CrossRefPubMed Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists’ attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000; 77: 781-793.CrossRefPubMed
32.
go back to reference Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash). 2002; 42: S58-S61.CrossRef Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash). 2002; 42: S58-S61.CrossRef
33.
go back to reference Simmonds L, Coomber R. Injecting drug users: a stigmatised and stigmatising population. Int J Drug Policy. 2009; 20: 121-130.CrossRefPubMed Simmonds L, Coomber R. Injecting drug users: a stigmatised and stigmatising population. Int J Drug Policy. 2009; 20: 121-130.CrossRefPubMed
34.
go back to reference Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002; 42: 40-45.CrossRef Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002; 42: 40-45.CrossRef
35.
go back to reference Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S83-S87.CrossRef Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S83-S87.CrossRef
Metadata
Title
Should Pharmacists have a Role in Harm Reduction Services for IDUs? A Qualitative Study in Tallinn, Estonia
Authors
Sigrid Vorobjov
Anneli Uusküla
Katri Abel-Ollo
Ave Talu
Don Des Jarlais
Publication date
01-11-2009
Publisher
Springer US
Published in
Journal of Urban Health / Issue 6/2009
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-009-9400-5

Other articles of this Issue 6/2009

Journal of Urban Health 6/2009 Go to the issue